RECAP April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%. Stocks closed lower, the$S&P 500 Index(.SPX.US)$was recently down about 0.72%.$NASDAQ 100 Index(.NDX.US)$fell about 0.94%.$NYダウ(.DJI.US)$fell 1%. MACRO Job openings recorded by JOLTS were just shy of expectations...
42
4
15
報告
binjh :
Well, they do say sell in May and go away.
KL6808 :
Bear trap, value trap or whatsoever, I belong to the old school where only death and taxes are certain. If history always repeat itself, then no one will lose a dime. Ask yourself what you are, intraday, medium, long term trader, what are your core holdings and what are your tactical, speculative bets? It's always good to take some money off the table if the underlying hit their ATH. If you ain't so lucky as some are approaching their ATL, then should you cut some losses? Meanwhile, some guru, big fund managers are talking about three rate cuts this year, but don't bet on it that they will come soon. Even if they do, or if the cuts are more than 25bp, then you better be worried that FED might have seen something coming, eg a worst off recession and a potential harder landing than the markets expect.
Recent insider selling at Molina Healthcare may hint at insiders believing the shares are overpriced. Despite profitability and profit growth, the absence of insider buying and recent selling could caution investors.
Analysts' sentiment remains steady post latest results, with a minor rise in revenue forecasts. Despite EPS missing estimates, earnings continue to be the value driver. Molina Healthcare's revenue growth rate is expected to surpass the industry.
Molina Healthcare's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors see insignificant potential for earnings deterioration, hence a lower P/E ratio isn't warranted. Share price drop in near future is unlikely.
Molina Healthcare's falling ROCE and rising capital without sales growth are concerning. Despite earlier impressive returns, future high multiplier chances seem slim given current trends.
Recent insider selling could trigger shareholder concern. However, notable company profitability growth and significant insider ownership remain positive signals. The selling activity despite the stock's higher current price suggests insiders view the lower price as fair, hinting at a cautious outlook.
Molina Healthcare's satisfactory performance linked to a high ROE and profit reinvestment supports solid earning growth. Consider if projected earnings growth impacts the stock price and if their P/E ratio is industry-commensurate.
binjh : Well, they do say sell in May and go away.
Power Bull : Good update. Keep it coming
eldritch : market is bleeding right now bears got it on lock for now it can only rise
KL6808 : Bear trap, value trap or whatsoever, I belong to the old school where only death and taxes are certain.
If history always repeat itself, then no one will lose a dime.
Ask yourself what you are, intraday, medium, long term trader, what are your core holdings and what are your tactical, speculative bets?
It's always good to take some money off the table if the underlying hit their ATH. If you ain't so lucky as some are approaching their ATL, then should you cut some losses?
Meanwhile, some guru, big fund managers are talking about three rate cuts this year, but don't bet on it that they will come soon. Even if they do, or if the cuts are more than 25bp, then you better be worried that FED might have seen something coming, eg a worst off recession and a potential harder landing than the markets expect.